Pernix Therapeutics Holdings Inc. isa specialty pharmaceutical company focused on the sales marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a variety of therapeutic areas.


Updates from The Motley Fool

Latest updates on Pernix Therapeutics Holdings from Fool.com.


Stock Performance

View Interactive PTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Pernix Therapeutics Holdings.
Current Price: $3.45
Prev Close: $3.44
Open: $3.44
Bid: $3.40
Ask: $3.60
Day's Range: $3.42 - $3.53
52wk Range: $1.83 - $10.40
Volume: 269,459
Avg Vol 197,530
Market Cap: $35M
P/E (ttm): -0.17
EPS (ttm): ($20.37)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Pernix Therapeutics Holdings.
CAPS Rating 0 out of 5
 
0 Outperform
3 Underperform
CAPS All Stars
 
0 Outperform
3 Underperform

How do you think Pernix Therapeutics Holdings will perform against the market?



You pick for Pernix Therapeutics Holdings is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Cooper C. Collins, CEO

0% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Pernix Therapeutics Holdings.

Pernix Therapeutics Holdings Inc. isa specialty pharmaceutical company focused on the sales marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a variety of therapeutic areas.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers